Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLOAGO IVF luteal support trial
2023-505126-34-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2023
- Modality
- Small Molecules, Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of triptorelin, recombinant human chorionic gonadotrophin, nafarelin and progesterone in infertility (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Live birth. Planned start Oct 2023; status: authorised.
02
Drugs
triptorelinrecombinant human chorionic gonadotrophinnafarelinprogesterone
03
Conditions
infertility
Beyond the preview
Go deeper on 2023-505126-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505126-34-00.